Henry Ford Health System is notifying patients who received a medication called D50 (dextrose 50 percent) during their hospitalization at Henry Ford Hospital in Detroit sometime between July 25, 2013 and Oct. 16, 2013.
We have found no evidence of patient harm.
However, to protect the safety of our patients, we want to know whether you have experienced any of the following symptoms since leaving the hospital:
- Shortness of breath
- Pain experienced with taking a deep breath
These symptoms could be a sign of illness that needs to be treated. These symptoms can be treated with medication.
If you have experienced any of these symptoms, and you are a patient who received a medication called D50 (dextrose 50 percent) during your hospitalization at Henry Ford Hospital in Detroit sometime between July 25, 2013 and Oct. 16, 2013, please contact us at 313.874.7733 or by email.
This situation does not affect patients hospitalized at other Henry Ford hospitals.
The D50 medication was part of a voluntary recall of medications produced and distributed by Specialty Medicine Compounding Pharmacy in South Lyon, Mich. The recall was issued Oct. 18, two days after a Henry Ford Hospital pharmacy technician discovered several sealed vials of the D50 medication that contained suspicious particles.